Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Influence of an Anomalous Temperature Dependence of the Phase Coherence Length on the Conductivity of Magnetic Topological Insulators.

Tkáč V, Výborný K, Komanický V, Warmuth J, Michiardi M, Ngankeu AS, Vondráček M, Tarasenko R, Vališka M, Stetsovych V, Carva K, Garate I, Bianchi M, Wiebe J, Holý V, Hofmann P, Springholz G, Sechovský V, Honolka J.

Phys Rev Lett. 2019 Jul 19;123(3):036406. doi: 10.1103/PhysRevLett.123.036406.

PMID:
31386447
2.

Chemical composition of industrially and laboratory processed Cyperus esculentus rhizomes.

Vega-Morales T, Mateos-Díaz C, Pérez-Machín R, Wiebe J, Gericke NP, Alarcón C, López-Romero JM.

Food Chem. 2019 Nov 1;297:124896. doi: 10.1016/j.foodchem.2019.05.170. Epub 2019 May 24.

PMID:
31253254
3.

Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography.

Hoppmann P, Rai H, Colleran R, Kufner S, Wiebe J, Cassese S, Joner M, Laugwitz KL, Kastrati A, Byrne RA.

Cardiovasc Revasc Med. 2019 May 30. pii: S1553-8389(19)30322-7. doi: 10.1016/j.carrev.2019.05.023. [Epub ahead of print]

PMID:
31231028
4.

Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome.

Nef HM, Wiebe J, Schmidt G, Möllmann H, Boeder NF, Dörr O, Bauer T, Blachutzik F, Liebetrau C, Elsässer A, Foin N, Hamm CW.

Herz. 2019 Jun 17. doi: 10.1007/s00059-019-4822-7. [Epub ahead of print]

PMID:
31209520
5.

Stabilizing spin systems via symmetrically tailored RKKY interactions.

Hermenau J, Brinker S, Marciani M, Steinbrecher M, Dos Santos Dias M, Wiesendanger R, Lounis S, Wiebe J.

Nat Commun. 2019 Jun 12;10(1):2565. doi: 10.1038/s41467-019-10516-2.

6.

Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stent.

Rai H, Hussein H, Colleran R, Xhepa E, Wiebe J, Pinieck S, Cassese S, Joner M, Kastrati A, Byrne RA, Foley DP.

Cardiovasc Revasc Med. 2019 May 8. pii: S1553-8389(19)30302-1. doi: 10.1016/j.carrev.2019.05.004. [Epub ahead of print]

PMID:
31155492
7.

Enhancement of Exercise Performance by 48 Hours, and 15-Day Supplementation with Mangiferin and Luteolin in Men.

Gelabert-Rebato M, Wiebe JC, Martin-Rincon M, Galvan-Alvarez V, Curtelin D, Perez-Valera M, Habib JJ, Pérez-López A, Vega T, Morales-Alamo D, Calbet JAL.

Nutrients. 2019 Feb 6;11(2). pii: E344. doi: 10.3390/nu11020344.

8.

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.

Byrne RA, Alfonso F, Schneider S, Maeng M, Wiebe J, Kretov E, Bradaric C, Rai H, Cuesta J, Rivero F, Hoppmann P, Schlichtenmaier J, Christiansen EH, Cassese S, Joner M, Schunkert H, Laugwitz KL, Kastrati A.

Eur Heart J. 2019 Jan 7;40(2):167-176. doi: 10.1093/eurheartj/ehy710.

PMID:
30520980
9.

Author Correction: Non-collinear spin states in bottom-up fabricated atomic chains.

Steinbrecher M, Rausch R, That KT, Hermenau J, Khajetoorians AA, Potthoff M, Wiesendanger R, Wiebe J.

Nat Commun. 2018 Nov 19;9(1):4925. doi: 10.1038/s41467-018-07428-y.

10.

Toxicological assessment of Xanthigen® nutraceutical extract combination: Mutagenicity, genotoxicity and oral toxicity.

López-Rios L, Vega T, Chirino R, Jung JC, Davis B, Pérez-Machín R, Wiebe JC.

Toxicol Rep. 2018 Oct 9;5:1021-1031. doi: 10.1016/j.toxrep.2018.10.007. eCollection 2018.

11.

Sex and Long-Term Outcomes After Implantation of Absorb Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease.

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss HD, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne RA, Laugwitz KL, Schunkert H, Massberg S, Kastrati A, Mehilli J.

EuroIntervention. 2018 Aug 14. pii: EIJ-D-18-00603. doi: 10.4244/EIJ-D-18-00603. [Epub ahead of print]

12.

Engineering the spin couplings in atomically crafted spin chains on an elemental superconductor.

Kamlapure A, Cornils L, Wiebe J, Wiesendanger R.

Nat Commun. 2018 Aug 14;9(1):3253. doi: 10.1038/s41467-018-05701-8.

13.

Non-collinear spin states in bottom-up fabricated atomic chains.

Steinbrecher M, Rausch R, That KT, Hermenau J, Khajetoorians AA, Potthoff M, Wiesendanger R, Wiebe J.

Nat Commun. 2018 Jul 20;9(1):2853. doi: 10.1038/s41467-018-05364-5. Erratum in: Nat Commun. 2018 Nov 19;9(1):4925.

14.

Mangifera indica L. Leaf Extract in Combination With Luteolin or Quercetin Enhances VO2peak and Peak Power Output, and Preserves Skeletal Muscle Function During Ischemia-Reperfusion in Humans.

Gelabert-Rebato M, Wiebe JC, Martin-Rincon M, Gericke N, Perez-Valera M, Curtelin D, Galvan-Alvarez V, Lopez-Rios L, Morales-Alamo D, Calbet JAL.

Front Physiol. 2018 Jun 8;9:740. doi: 10.3389/fphys.2018.00740. eCollection 2018.

15.

A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study.

Nef H, Wiebe J, Boeder N, Dörr O, Bauer T, Hauptmann KE, Latib A, Colombo A, Fischer D, Rudolph T, Foin N, Richardt G, Hamm C.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1021-1027. doi: 10.1002/ccd.27550. Epub 2018 Mar 6.

PMID:
29508518
16.

Long Spin-Relaxation Times in a Transition-Metal Atom in Direct Contact to a Metal Substrate.

Hermenau J, Ternes M, Steinbrecher M, Wiesendanger R, Wiebe J.

Nano Lett. 2018 Mar 14;18(3):1978-1983. doi: 10.1021/acs.nanolett.7b05392. Epub 2018 Feb 26.

PMID:
29466854
17.

Acculturation, family cohesion, and mental health among Latinos living with HIV on the U.S.-Mexico border.

Sauceda JA, Wiebe JS, Chan K, Kutner BA, Simoni JM.

Cultur Divers Ethnic Minor Psychol. 2018 Jul;24(3):453-458. doi: 10.1037/cdp0000166. Epub 2018 Feb 1.

18.

Electronic structure of Fe1.08Te bulk crystals and epitaxial FeTe thin films on Bi2Te3.

Arnold F, Warmuth J, Michiardi M, Fikáček J, Bianchi M, Hu J, Mao Z, Miwa J, Raj Singh U, Bremholm M, Wiesendanger R, Honolka J, Wehling T, Wiebe J, Hofmann P.

J Phys Condens Matter. 2018 Jan 12;30(6):065502. doi: 10.1088/1361-648X/aaa43e. [Epub ahead of print]

PMID:
29327694
19.

Development and Psychometric Evaluation of the Brief Adolescent Gambling Screen (BAGS).

Stinchfield R, Wynne H, Wiebe J, Tremblay J.

Front Psychol. 2017 Dec 19;8:2204. doi: 10.3389/fpsyg.2017.02204. eCollection 2017.

20.

Electronic Structure of Fe<sub>1.08</sub>Te bulk crystals and epitaxial FeTe thin films on Bi<sub>2</sub>Te<sub>3</sub>.

Arnold F, Warmuth J, Michiardi M, Fikaček J, Bianchi M, Hu J, Mao Z, Miwa JA, Singh UR, Bremholm M, Wiesendanger R, Honolka J, Wehling TO, Wiebe J, Hofmann P.

J Phys Condens Matter. 2017 Dec 28. doi: 10.1088/1361-648X/aaa43e. [Epub ahead of print]

PMID:
29283106
21.

Spin-Resolved Spectroscopy of the Yu-Shiba-Rusinov States of Individual Atoms.

Cornils L, Kamlapure A, Zhou L, Pradhan S, Khajetoorians AA, Fransson J, Wiebe J, Wiesendanger R.

Phys Rev Lett. 2017 Nov 10;119(19):197002. doi: 10.1103/PhysRevLett.119.197002. Epub 2017 Nov 9.

PMID:
29219531
22.

Cross Validation of the Gambling Problem Severity Subscale of the Canadian Adolescent Gambling Index (CAGI/GPSS) on a Sample of Ontario High School Students.

Turner NE, Elton-Marshall T, Shi J, Wiebe J, Boak A, van der Maas M, Mann RE.

J Gambl Stud. 2018 Jun;34(2):521-537. doi: 10.1007/s10899-017-9731-1.

23.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ, Gomez-Lara J, Timmers L, Motreff P, Hoppmann P, Abdel-Wahab M, Byrne RA, Meincke F, Boeder N, Honton B, O'Sullivan CJ, Ielasi A, Delarche N, Christ G, Lee JKT, Lee M, Amabile N, Karagiannis A, Windecker S, Räber L.

J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.

24.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.

Capranzano P, Capodanno D, Brugaletta S, Latib A, Mehilli J, Nef H, Gori T, Lesiak M, Geraci S, Pyxaras S, Mattesini A, Münzel T, Araszkiewicz A, Caramanno G, Naber C, Di Mario C, Sabatè M, Colombo A, Wiebe J, Tamburino C.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):444-453. doi: 10.1002/ccd.27388. Epub 2017 Oct 25.

PMID:
29068130
25.

NLPReViz: an interactive tool for natural language processing on clinical text.

Trivedi G, Pham P, Chapman WW, Hwa R, Wiebe J, Hochheiser H.

J Am Med Inform Assoc. 2018 Jan 1;25(1):81-87. doi: 10.1093/jamia/ocx070.

26.

A gateway towards non-collinear spin processing using three-atom magnets with strong substrate coupling.

Hermenau J, Ibañez-Azpiroz J, Hübner C, Sonntag A, Baxevanis B, Ton KT, Steinbrecher M, Khajetoorians AA, Dos Santos Dias M, Blügel S, Wiesendanger R, Lounis S, Wiebe J.

Nat Commun. 2017 Sep 21;8(1):642. doi: 10.1038/s41467-017-00506-7.

27.

Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.

Giacoppo D, Colleran R, Cassese S, Frangieh AH, Wiebe J, Joner M, Schunkert H, Kastrati A, Byrne RA.

JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.

28.

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

Nef HM, Wiebe J, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, Richardt G, Schmermund A, Woehrle J, Zahn R, Riemer T, Achenbach S, Hamm CW.

EuroIntervention. 2017 Dec 20;13(11):1311-1318. doi: 10.4244/EIJ-D-17-00330.

29.

Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB Registry.

Wiebe J, Hoppmann P, Colleran R, Kufner S, Valeskini M, Cassese S, Schneider S, Joner M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1222-1229. doi: 10.1016/j.jcin.2017.03.029.

30.

Use of the 2008 Basel Consensus Statements to Assess, Realign, and Monitor Pharmacy Practice at a Tertiary Care Hospital in Northern Uganda: Illustrative Case Study, Part 2.

Stacey D, Vaillancourt R, Brander L, Chenel N, McMahon E, Wiebe J, Kirkwood A, Shaka G, Cheng D.

Can J Hosp Pharm. 2017 Jan-Feb;70(1):35-46. Epub 2017 Feb 28. No abstract available.

31.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabate M, Tamburino C, Nef H, Gori T.

EuroIntervention. 2017 Oct 13;13(9):e1104-e1111. doi: 10.4244/EIJ-D-16-00568.

32.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

Geraci S, Kawamoto H, Caramanno G, Ruparelia N, Capodanno D, Brugaletta S, Gori T, Nef H, Sabate M, Mehilli J, Lesiak M, Naber C, Di Mario C, Capranzano P, Wiebe J, Araszkiewicz A, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):560-568. doi: 10.1016/j.jcin.2016.12.013. Epub 2017 Mar 1.

33.

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

EuroIntervention. 2017 Apr 20;12(17):2110-2117. doi: 10.4244/EIJ-D-16-00974.

PMID:
28246060
34.

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison.

Wiebe J, Dörr O, Ilstad H, Husser O, Liebetrau C, Boeder N, Bauer T, Möllmann H, Kastrati A, Hamm CW, Nef HM.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):477-485. doi: 10.1016/j.jcin.2016.11.034. Epub 2017 Feb 15.

35.

Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation.

Wiebe J, Dörr O, Liebetrau C, Bauer T, Wilkens E, Ilstad H, Boeder N, Elsässer A, Möllmann H, Hamm CW, Nef HM.

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1144-1151. doi: 10.1016/j.rec.2016.08.012. Epub 2016 Oct 27. English, Spanish.

PMID:
28134094
36.

Interfacial superconductivity in a bi-collinear antiferromagnetically ordered FeTe monolayer on a topological insulator.

Manna S, Kamlapure A, Cornils L, Hänke T, Hedegaard EM, Bremholm M, Iversen BB, Hofmann P, Wiebe J, Wiesendanger R.

Nat Commun. 2017 Jan 17;8:14074. doi: 10.1038/ncomms14074.

37.

Reorientation of the diagonal double-stripe spin structure at Fe1+yTe bulk and thin-film surfaces.

Hänke T, Singh UR, Cornils L, Manna S, Kamlapure A, Bremholm M, Hedegaard EM, Iversen BB, Hofmann P, Hu J, Mao Z, Wiebe J, Wiesendanger R.

Nat Commun. 2017 Jan 6;8:13939. doi: 10.1038/ncomms13939.

38.

Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.

Blachutzik F, Boeder N, Wiebe J, Mattesini A, Dörr O, Most A, Bauer T, Tröbs M, Röther J, Schlundt C, Achenbach S, Hamm C, Nef H.

Heart Vessels. 2017 Jul;32(7):781-789. doi: 10.1007/s00380-016-0932-9. Epub 2016 Dec 21.

PMID:
28004176
39.

Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis.

Boeder NF, Johnson V, Dörr O, Wiebe J, Elsässer A, Möllmann H, Hamm CW, Nef HM, Bauer T.

Int J Cardiol. 2017 Mar 15;231:73-77. doi: 10.1016/j.ijcard.2016.11.280. Epub 2016 Nov 24.

PMID:
27899203
40.

A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.

Nef HM, Wiebe J, Foin N, Blachutzik F, Dörr O, Toyloy S, Hamm CW.

Int J Cardiol. 2017 Jan 15;227:127-133. doi: 10.1016/j.ijcard.2016.11.033. Epub 2016 Nov 9. Review.

PMID:
27863289
41.

Structural and electronic properties of ultrathin FeSe films grown on Bi2Se3(0 0 0 1) studied by STM/STS.

Singh UR, Warmuth J, Markmann V, Wiebe J, Wiesendanger R.

J Phys Condens Matter. 2017 Jan 18;29(2):025004. Epub 2016 Nov 14.

PMID:
27841999
42.

The heart of the matter: Outcome reporting bias and registration status in cardio-thoracic surgery.

Wiebe J, Detten G, Scheckel C, Gearhart D, Wheeler D, Sanders D, Vassar M.

Int J Cardiol. 2017 Jan 15;227:299-304. doi: 10.1016/j.ijcard.2016.11.098. Epub 2016 Nov 8.

PMID:
27839821
43.

Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.

Blachutzik F, Boeder N, Wiebe J, Mattesini A, Dörr O, Most A, Bauer T, Röther J, Tröbs M, Schlundt C, Achenbach S, Hamm CW, Nef HM.

Clin Res Cardiol. 2017 Apr;106(4):271-279. doi: 10.1007/s00392-016-1048-z. Epub 2016 Oct 18.

PMID:
27757522
44.

Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.

Ortega-Paz L, Capodanno D, Giacchi G, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

Catheter Cardiovasc Interv. 2017 Apr;89(5):812-818. doi: 10.1002/ccd.26674. Epub 2016 Aug 12.

PMID:
27515568
45.

Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents.

Cassese S, Hoppmann P, Kufner S, Byrne RA, Wiebe J, Colleran R, Giacoppo D, Harada Y, Laugwitz KL, Schunkert H, Fusaro M, Kastrati A.

Circ Cardiovasc Interv. 2016 Aug;9(8). pii: e003698. doi: 10.1161/CIRCINTERVENTIONS.116.003698.

PMID:
27512088
46.

Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.

Naganuma T, Colombo A, Lesiak M, Capodanno D, Gori T, Nef H, Caramanno G, Naber C, Di Mario C, Ruparelia N, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Kawamoto H, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Latib A.

Catheter Cardiovasc Interv. 2017 Jan;89(1):47-56. doi: 10.1002/ccd.26634. Epub 2016 Jul 14.

PMID:
27414021
47.

Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.

Colleran R, Kufner S, Harada Y, Giacoppo D, Cassese S, Repp J, Wiebe J, Lohaus R, Lahmann A, Schneider S, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA; Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Investigators.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):367-374. doi: 10.1002/ccd.26597. Epub 2016 Jul 5.

PMID:
27377301
48.

Drug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis.

Wiebe J, Colleran R, Kastrati A.

JACC Cardiovasc Interv. 2016 Jun 27;9(12):1256-8. doi: 10.1016/j.jcin.2016.05.007. Epub 2016 Jun 20. No abstract available.

49.

Factors Associated with Sexual Risk of HIV Transmission Among HIV-Positive Latino Men Who have Sex with Men on the U.S.-México Border.

Kutner BA, Nelson KM, Simoni JM, Sauceda JA, Wiebe JS.

AIDS Behav. 2017 Mar;21(3):923-934. doi: 10.1007/s10461-016-1449-z.

50.

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry.

Wiebe J, Hoppmann P, Kufner S, Harada Y, Colleran R, Michel J, Giacoppo D, Schneider S, Cassese S, Ibrahim T, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA.

EuroIntervention. 2016 Jun 12;12(2):e137-43. doi: 10.4244/EIJY16M05_03.

Supplemental Content

Support Center